Health
Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes – News-Medical.Net
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress …
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress 2020.
Angina refers to constricting pain or discomfort in the front of the chest or in the neck, jaw, shoulder, or arm due to reduced blood flow to the heart. It can occur during acute coronary syndromes (ACS) and chronic coronary syndromes…
-
Noosa News20 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News20 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
General17 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business21 hours ago16 ASX 200 shares roar to multi-year highs amid new market milestone